Different Phenotypes in Asthma: Clinical Findings and Experimental Animal Models

Imagem de Miniatura
Arquivos
art_LOURENCO_Different_Phenotypes_in_Asthma_Clinical_Findings_and_Experimental_2022.PDF (1.49 MB)
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
HUMANA PRESS INC
Autores
LOURENCO, Luiz Otavio
RIBEIRO, Alessandra Mussi
TAVARES-DE-LIMA, Wothan
Citação
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, v.62, n.1, Special Issue, p.240-263, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Asthma is a respiratory allergic disease presenting a high prevalence worldwide, and it is responsible for several complications throughout life, including death. Fortunately, asthma is no longer recognized as a unique manifestation but as a very heterogenic manifestation. Its phenotypes and endotypes are known, respectively, as pathologic and molecular features that might not be directly associated with each other. The increasing number of studies covering this issue has brought significant insights and knowledge that are constantly expanding. In this review, we intended to summarize this new information obtained from clinical studies, which not only allowed for the creation of patient clusters by means of personalized medicine and a deeper molecular evaluation, but also created a connection with data obtained from experimental models, especially murine models. We gathered information regarding sensitization and trigger and emphasizing the most relevant phenotypes and endotypes, such as Th2-(high) asthma and Th2-(low) asthma, which included smoking and obesity-related asthma and mixed and paucigranulocytic asthma, not only in physiopathology and the clinic but also in how these phenotypes can be determined with relative similarity using murine models. We also further investigated how clinical studies have been treating patients using newly developed drugs focusing on specific biomarkers that are more relevant according to the patient's clinical manifestation of the disease.
Palavras-chave
Asthma, Animal models, Clinical data, Phenotypes
URI
https://observatorio.fm.usp.br/handle/OPI/45850
Referências
  1. Acciani TH, 2013, CLIN EXP ALLERGY, V43, P1406, DOI 10.1111/cea.12200
  2. Achakulwisut P, 2019, LANCET PLANET HEALTH, V3, pE166, DOI 10.1016/S2542-5196(19)30046-4
  3. Agache I, 2020, ALLERGY, V75, P1023, DOI 10.1111/all.14221
  4. Agache I, 2019, J CLIN INVEST, V129, P1493, DOI 10.1172/JCI124611
  5. Akdis M, 2016, J ALLERGY CLIN IMMUN, V138, P984, DOI 10.1016/j.jaci.2016.06.033
  6. Al-Alwan A, 2014, AM J RESP CRIT CARE, V189, P1494, DOI 10.1164/rccm.201401-0178OC
  7. Al-Harbi NO, 2019, EUR J PHARMACOL, V855, P276, DOI 10.1016/j.ejphar.2019.05.026
  8. Alberg T, 2009, J TOXICOL ENV HEAL A, V72, P1, DOI 10.1080/15287390802414471
  9. Albers FC, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1134-7
  10. Amrani Y, 2004, CURR OPIN PHARMACOL, V4, P230, DOI 10.1016/j.coph.2004.02.004
  11. Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X
  12. Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC
  13. Haldar P, 2007, J ALLERGY CLIN IMMUN, V119, P1043, DOI 10.1016/j.jaci.2007.02.042
  14. Harb H, 2020, CLIN EXP ALLERGY, V50, P5, DOI 10.1111/cea.13491
  15. Haspeslagh E, 2017, METHODS MOL BIOL, V1559, P121, DOI 10.1007/978-1-4939-6786-5_10
  16. Hastie AT, 2013, J ALLERGY CLIN IMMUN, V132, P72, DOI 10.1016/j.jaci.2013.03.044
  17. He ZG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1223-4
  18. Hekking PPW, 2014, J ALLER CL IMM-PRACT, V2, P671, DOI 10.1016/j.jaip.2014.09.007
  19. Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108, DOI 10.1164/ajrccm.165.1.2105051
  20. Hew M, 2020, J ALLER CL IMM-PRACT, V8, P2222, DOI 10.1016/j.jaip.2020.02.036
  21. Komi DEA, 2019, CLIN REV ALLERG IMMU, V56, P234, DOI 10.1007/s12016-018-8720-1
  22. Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133
  23. Hirota JA, 2009, PULM PHARMACOL THER, V22, P370, DOI 10.1016/j.pupt.2008.12.004
  24. Hong JY, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-63
  25. Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020
  26. Hsu CL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226701
  27. Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283
  28. Humeniuk P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071491
  29. Ibrahim H, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1251-3
  30. Ito K, 2008, AM J RESP CELL MOL, V39, P543, DOI 10.1165/rcmb.2008-0028OC
  31. Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
  32. Ano S, 2013, J IMMUNOL, V190, P1056, DOI 10.4049/jimmunol.1202386
  33. Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC
  34. Kubo M, 2017, IMMUNOL REV, V278, P162, DOI 10.1111/imr.12557
  35. Kumar RK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00312
  36. KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278
  37. Kuruvilla ME, 2019, CLIN REV ALLERG IMMU, V56, P219, DOI 10.1007/s12016-018-8712-1
  38. Lambrecht BN, 2019, IMMUNITY, V50, P975, DOI 10.1016/j.immuni.2019.03.018
  39. Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049
  40. Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472
  41. Leitch VD, 2009, IMMUNOL CELL BIOL, V87, P131, DOI 10.1038/icb.2008.72
  42. Liang L, 2018, KOREAN J INTERN MED, V33, P1210, DOI 10.3904/kjim.2017.207
  43. Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791
  44. Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018
  45. [Anonymous], 2019, N Engl J Med, V380, P2082, DOI 10.1056/NEJMx180026
  46. Liu WM, 2017, J ALLERGY CLIN IMMUN, V139, P1548, DOI 10.1016/j.jaci.2016.08.032
  47. Lombardi C, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-016-0138-8
  48. Lombardi V, 2010, INT ARCH ALLERGY IMM, V151, P179, DOI 10.1159/000242355
  49. Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037
  50. Maddur MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5092
  51. Madore AM, 2010, J ASTHMA ALLERGY, V3, P107, DOI 10.2147/JAA.S8970
  52. Maltby S, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-032877
  53. Matsuse H, 2013, RESPIRATION, V85, P429, DOI 10.1159/000345861
  54. McBrien CN, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00093
  55. Wong EHC, 2014, LANCET RESP MED, V2, P657, DOI 10.1016/S2213-2600(14)70107-9
  56. McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089
  57. Apter AJ, 2019, J ALLERGY CLIN IMMUN, V143, P1336, DOI 10.1016/j.jaci.2018.12.1005
  58. Mohanan S, 2014, EXP BIOL MED, V239, P1531, DOI 10.1177/1535370214525302
  59. Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC
  60. Murdoch JR, 2010, MUTAT RES-FUND MOL M, V690, P24, DOI 10.1016/j.mrfmmm.2009.09.005
  61. Network GA, 2018, GLOB ASTHM REP
  62. Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323
  63. Nissen G, 2018, CLIN EXP ALLERGY, V48, P1483, DOI 10.1111/cea.13236
  64. Ntontsi P, 2017, ALLERGY, V72, P1761, DOI 10.1111/all.13184
  65. Ochkur SI, 2007, J IMMUNOL, V178, P7879, DOI 10.4049/jimmunol.178.12.7879
  66. Wypych TP, 2018, J ALLERGY CLIN IMMUN, V141, P1395, DOI 10.1016/j.jaci.2017.09.001
  67. Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290
  68. Ozdemir C, 2018, EXPERT REV RESP MED, V12, P733, DOI 10.1080/17476348.2018.1505507
  69. Asai-Tajiri Y, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0132-z
  70. Panettieri RA, 2018, LANCET RESP MED, V6, P511, DOI 10.1016/S2213-2600(18)30184-X
  71. Panettieri RA, 2016, IMMUNOL ALLERGY CLIN, V36, P569, DOI 10.1016/j.iac.2016.03.007
  72. Papi A, 2018, LANCET, V391, P783, DOI 10.1016/S0140-6736(17)33311-1
  73. Pelaia G, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/879783
  74. Peters MC, 2019, AM J RESP CRIT CARE, V199, P465, DOI 10.1164/rccm.201807-1291OC
  75. Peters U, 2018, J ALLERGY CLIN IMMUN, V141, P1169, DOI 10.1016/j.jaci.2018.02.004
  76. Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205
  77. Xu XC, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/8254909
  78. Platts-Mills TAE, 2016, J ALLERGY CLIN IMMUN, V137, P1662, DOI 10.1016/j.jaci.2016.04.010
  79. Polosa R, 2013, EUR RESPIR J, V41, P716, DOI 10.1183/09031936.00073312
  80. Poulsen LK, 2007, ANN MED, V39, P440, DOI 10.1080/07853890701449354
  81. Athari SS, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0079-0
  82. Prado CM, 2011, EXP LUNG RES, V37, P259, DOI 10.3109/01902148.2010.538289
  83. Ray A, 2017, TRENDS IMMUNOL, V38, P942, DOI 10.1016/j.it.2017.07.003
  84. Ray A, 2015, AM J PHYSIOL-LUNG C, V308, pL130, DOI 10.1152/ajplung.00070.2014
  85. Reynolds G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00330
  86. ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504
  87. Rosenberg HF, 2018, J LEUKOCYTE BIOL, V104, P41, DOI 10.1002/JLB.3MR1117-436R
  88. Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056
  89. Sagar S, 2015, EUR J PHARMACOL, V759, P272, DOI 10.1016/j.ejphar.2015.03.037
  90. Salter BM, 2017, CHEST, V152, P410, DOI 10.1016/j.chest.2017.01.021
  91. Santana FPR, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/1356356
  92. Serra MF, 2018, J IMMUNOL, V201, P851, DOI 10.4049/jimmunol.1700933
  93. Aun MV, 2017, J ASTHMA ALLERGY, V10, P293, DOI 10.2147/JAA.S121092
  94. Shinagawa K, 2003, AM J RESP CRIT CARE, V168, P959, DOI 10.1164/rccm.200210-1188OC
  95. Shore SA, 2007, J APPL PHYSIOL, V102, P516, DOI 10.1152/japplphysiol.00847.2006
  96. Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810
  97. Skloot GS, 2016, CURR OPIN PULM MED, V22, P3, DOI 10.1097/MCP.0000000000000225
  98. Southam DS, 2005, J ALLERGY CLIN IMMUN, V115, P95, DOI 10.1016/j.jaci.2004.09.022
  99. Yang M, 2009, J IMMUNOL, V182, P5107, DOI 10.4049/jimmunol.0803468
  100. Spears M, 2006, CLIN EXP ALLERGY, V36, P1494, DOI 10.1111/j.1365-2222.2006.02604.x
  101. Tamiya T, 2013, J IMMUNOL, V191, P2360, DOI 10.4049/jimmunol.1301276
  102. Tanaka H, 2004, AM J RESP CELL MOL, V31, P62, DOI 10.1165/rcmb.2003-0305OC
  103. Nguyen TH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163392
  104. Thiriou D, 2017, INT IMMUNOPHARMACOL, V48, P43, DOI 10.1016/j.intimp.2017.04.027
  105. Ban GY, 2017, CLIN EXP ALLERGY, V47, P37, DOI 10.1111/cea.12797
  106. Tliba O, 2019, J ALLERGY CLIN IMMUN, V143, P1287, DOI 10.1016/j.jaci.2018.06.008
  107. Toledo AC, 2013, BRIT J PHARMACOL, V168, P1736, DOI 10.1111/bph.12062
  108. Tung HY, 2018, SEMIN RESP CRIT CARE, V39, P64, DOI 10.1055/s-0037-1607981
  109. van der Ploeg EK, 2020, J INNATE IMMUN, V12, P47, DOI 10.1159/000496212
  110. Yang N, 2019, INT IMMUNOPHARMACOL, V72, P422, DOI 10.1016/j.intimp.2019.04.044
  111. Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017
  112. Walker JA, 2018, NAT REV IMMUNOL, V18, P121, DOI 10.1038/nri.2017.118
  113. Walker ML, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00447
  114. Wang W, 2018, J IMMUNOL, V201, P2221, DOI 10.4049/jimmunol.1800709
  115. Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048
  116. Wenzel SE, 2021, AM J RESP CRIT CARE, V203, P809, DOI 10.1164/rccm.202009-3631CI
  117. Barnes PJ, 2018, NAT REV IMMUNOL, V18, P454, DOI 10.1038/s41577-018-0006-6
  118. Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678
  119. Barnes PJ, 2010, PHARMACEUTICALS, V3, P514, DOI 10.3390/ph3030514
  120. Jonckheere AC, 2019, CURR OPIN ALLERGY CL, V19, P53, DOI 10.1097/ACI.0000000000000497
  121. Yang YS, 2008, TOX RESEARCH, V24, P253, DOI 10.5487/TR.2008.24.4.253
  122. Yasuda Y, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051178
  123. Youssef M, 2020, PHARM RES-DORDR, V37, DOI 10.1007/s11095-019-2743-z
  124. Yu QL, 2018, EXP THER MED, V15, P2492, DOI 10.3892/etm.2018.5721
  125. Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878
  126. Zhu LL, 2019, INT IMMUNOPHARMACOL, V67, P396, DOI 10.1016/j.intimp.2018.12.030
  127. Zhu LD, 2018, WORLD ALLERGY ORGAN, V11, DOI 10.1186/s40413-018-0208-1
  128. Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x
  129. Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119
  130. Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713
  131. Karrasch S, 2017, THORAX, V72, P109, DOI 10.1136/thoraxjnl-2016-208704
  132. Bates JHT, 2009, AM J PHYSIOL-LUNG C, V297, pL401, DOI 10.1152/ajplung.00027.2009
  133. Beavitt SJE, 2005, J IMMUNOL, V175, P1867, DOI 10.4049/jimmunol.175.3.1867
  134. Becker KL, 2015, CLIN EXP ALLERGY, V45, P423, DOI 10.1111/cea.12354
  135. Belvisi MG, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0799-7
  136. Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753
  137. Bhakta NR, 2011, IMMUNOL REV, V242, P220, DOI 10.1111/j.1600-065X.2011.01032.x
  138. Bonser LR, 2017, J CLIN MED, V6, DOI 10.3390/jcm6120112
  139. Branchett WJ, 2020, J ALLERGY CLIN IMMUN, V145, P666, DOI 10.1016/j.jaci.2019.08.006
  140. Brandt EB, 2020, CLIN EXP ALLERGY, V50, P121, DOI 10.1111/cea.13512
  141. Breiteneder H, 2020, ALLERGY, V75, P3039, DOI 10.1111/all.14582
  142. Kim DI, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-1001-9
  143. Brown JM, 2008, CLIN EXP ALLERGY, V38, P4, DOI 10.1111/j.1365-2222.2007.02886.x
  144. BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x
  145. Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC
  146. Camargo LD, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01835
  147. Caminati M, 2018, WORLD ALLERGY ORGAN, V11, DOI 10.1186/s40413-018-0192-5
  148. Canning BJ, 2008, PULM PHARMACOL THER, V21, P702, DOI 10.1016/j.pupt.2008.01.004
  149. Canonica GW, 2018, CURR OPIN ALLERGY CL, V18, P51, DOI 10.1097/ACI.0000000000000416
  150. Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619
  151. Chang Yoon-Seok, 2005, Korean Journal of Internal Medicine, V20, P152
  152. Chauhan PS, 2018, PHYTOMEDICINE, V51, P29, DOI 10.1016/j.phymed.2018.06.022
  153. Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391
  154. Chen BL, 2018, CLIN EXP ALLERGY, V48, P1494, DOI 10.1111/cea.13258
  155. Chen RC, 2017, AM J RESP CRIT CARE, V196, P700, DOI 10.1164/rccm.201612-2427OC
  156. Cherrier DE, 2018, IMMUNITY, V48, P1091, DOI 10.1016/j.immuni.2018.05.010
  157. Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133
  158. Choi IW, 2005, J ALLERGY CLIN IMMUN, V116, P537, DOI 10.1016/j.jaci.2005.05.034
  159. Colgan JD, 2010, CURR OPIN ALLERGY CL, V10, P42, DOI 10.1097/ACI.0b013e328334f642
  160. Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469
  161. De Vooght V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012581
  162. de Vries M P, 2005, Prim Care Respir J, V14, P210, DOI 10.1016/j.pcrj.2005.04.005
  163. Deckers J, 2013, TRENDS IMMUNOL, V34, P540, DOI 10.1016/j.it.2013.08.004
  164. Kinyanjui Elizabeth D, 2014, RESP RES, V15, DOI [10.1186/s12931-014-0090-5, DOI 10.1186/S12931-014-0090-5]
  165. Demarche S, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0208-2
  166. Dhami S, 2017, ALLERGY, V72, P1825, DOI 10.1111/all.13208
  167. Rodrigues APD, 2019, HISTOL HISTOPATHOL, V34, P537, DOI 10.14670/HH-18-059
  168. DIAZSANCHEZ D, 1994, J CLIN INVEST, V94, P1417, DOI 10.1172/JCI117478
  169. Ding FX, 2018, MED SCI MONITOR, V24, P3220, DOI 10.12659/MSM.905202
  170. Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009
  171. Domingo C, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0893-x
  172. dos Santos TM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01183
  173. Duechs MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091223
  174. Duffey H, 2019, IMMUNOL ALLERGY CLIN, V39, P561, DOI 10.1016/j.iac.2019.07.009
  175. Kippelen P, 2018, IMMUNOL ALLERGY CLIN, V38, P165, DOI 10.1016/j.iac.2018.01.008
  176. Essilfie AT, 2012, THORAX, V67, P588, DOI 10.1136/thoraxjnl-2011-200160
  177. Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786
  178. FAHY JV, 1995, AM J RESP CRIT CARE, V152, P53, DOI 10.1164/ajrccm.152.1.7599862
  179. Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082
  180. Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544
  181. Foster PS, 2017, IMMUNOL REV, V278, P20, DOI 10.1111/imr.12549
  182. Froidure A, 2016, EUR RESPIR J, V47, P304, DOI 10.1183/13993003.01824-2014
  183. Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126
  184. Gao H, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/3743048
  185. Gao W, 2020, BIOMARK MED, V14, P211, DOI 10.2217/bmm-2019-0487
  186. Koch S, 2017, SEMIN IMMUNOPATHOL, V39, P55, DOI 10.1007/s00281-016-0601-1
  187. Garcia G, 2013, CHEST, V144, P411, DOI 10.1378/chest.12-1961
  188. Gazi L, 2005, PROSTAG OTH LIPID M, V75, P153, DOI 10.1016/j.prostaglandins.2004.11.003
  189. Global Initiative for Asthma, 2019, GLOB STRAT ASTHM MAN
  190. Gon Y, 2018, ALLERGOL INT, V67, P12, DOI 10.1016/j.alit.2017.08.011
  191. Gonzalez D, 2019, J INVEST ALLERG CLIN, V29, P84, DOI 10.18176/jiaci.0385
  192. Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875
  193. Gu ZW, 2017, ONCOTARGET, V8, P22361, DOI 10.18632/oncotarget.15652
  194. Gubernatorova EO, 2019, IMMUNOL LETT, V207, P73, DOI 10.1016/j.imlet.2018.11.012
  195. Guia S, 2020, TRENDS IMMUNOL, V41, P436, DOI 10.1016/j.it.2020.03.002
  196. Guida G, 2019, SEMIN IMMUNOL, V46, DOI 10.1016/j.smim.2019.101346
  197. Komi DEA, 2020, CLIN REV ALLERG IMMU, V58, P377, DOI 10.1007/s12016-020-08779-5
  198. Hadebe S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134219

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/05
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - ODS/03